Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brightening Creams vs Laser Therapy in Skin Hyperpigmentation After Sclerotherapy
NCT05165524Completed
- Sponsor
- Insel Gruppe
- Start
- Mar 2022
- Primary completion
- Jan 2025
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial of pigmanorm in Hyperpigmentation (3 arms), sponsored by Insel Gruppe. Primary endpoint: Skin Hyperpigmentation Index at 16 weeks. Started Mar 2022; status: completed.
02
Drugs
pigmanorm
03
Conditions
Hyperpigmentation
Beyond the preview
Go deeper on NCT05165524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05165524.